Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilie Sanchez

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Ejhaem|July 18, 2022
Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti-CD19 CAR-T therapy: a case reportStrachan Mackenzie, Manar Shafat, Harriet Roddy, et al.
British Journal of Haematology|October 11, 2021
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factorsWei Yee Chan, Lara Howells, William Wilson, et al.
The Lancet. Rheumatology|January 23, 2024
Diagnosis and investigation of suspected haemophagocytic lymphohistiocytosis in adults: 2023 Hyperinflammation and HLH Across Speciality Collaboration (HiHASC) consensus guidelineMiriam F Cox, Strachan Mackenzie, Ryan Low, et al.
British Journal of Haematology|July 18, 2020
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapyThomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
British Journal of Haematology|October 26, 2020
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'Thomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
The Lancet. Infectious Diseases|April 15, 2021
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort studyDan Frampton, Tommy Rampling, Aidan Cross, et al.
Science (New York, N.Y.)|November 7, 2020
Preexisting and de novo humoral immunity to SARS-CoV-2 in humansKevin W Ng, Nikhil Faulkner, Georgina H Cornish, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Ejhaem|July 18, 2022
Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti-CD19 CAR-T therapy: a case reportStrachan Mackenzie, Manar Shafat, Harriet Roddy, et al.
British Journal of Haematology|October 11, 2021
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factorsWei Yee Chan, Lara Howells, William Wilson, et al.
The Lancet. Rheumatology|January 23, 2024
Diagnosis and investigation of suspected haemophagocytic lymphohistiocytosis in adults: 2023 Hyperinflammation and HLH Across Speciality Collaboration (HiHASC) consensus guidelineMiriam F Cox, Strachan Mackenzie, Ryan Low, et al.
British Journal of Haematology|July 18, 2020
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapyThomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
British Journal of Haematology|October 26, 2020
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'Thomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
The Lancet. Infectious Diseases|April 15, 2021
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort studyDan Frampton, Tommy Rampling, Aidan Cross, et al.
Science (New York, N.Y.)|November 7, 2020
Preexisting and de novo humoral immunity to SARS-CoV-2 in humansKevin W Ng, Nikhil Faulkner, Georgina H Cornish, et al.
Pageof 2